SCHEMBL8667927

SCHEMBL8667927

C=CCC[C](Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.41
CES2 O00748 1/20 0.41
AKR1B1 P15121 1/20 0.41
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
ACHE P22303 1/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAOB P27338 1/20 0.34
KEAP1 Q14145 1/20 0.34
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CTBP2 P56545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8673012 0.78 CES1 (0.44) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL7938314 0.78 CES1 (0.44) CES1CES2AKR1B1MEN1KMT2A
Phenylacetic Acid SCHEMBL31040659 0.78 AKR1B1 (0.57) CES1CES2AKR1B1GAATSHR
SCHEMBL9355161 0.76 CES1 (0.44) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL9359455 0.76 CES1 (0.44) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL4981463 0.74 CES1 (0.60) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL5371385 0.73 KEAP1 (0.56) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL8668103 0.71 CES2 (0.46) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL9348533 0.71 KEAP1 (0.53) HDAC8HDAC6ACHEALDH1A1KEAP1
SCHEMBL49747 0.70 ALDH1A1 (0.48) ALDH1A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed